Betaderm and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Betaderm (betamethasone valerate), especially for people who are male, 50-59 old, have been taking the drug for 5 - 10 years also take Cosentyx, and have Psoriasis.

The phase IV clinical study analyzes which people have Cellulitis when taking Betaderm. It is created by eHealthMe based on reports of 1,464 people who have side effects when taking Betaderm from the FDA, and is updated regularly.

What is Betaderm?

Betaderm has active ingredients of betamethasone valerate. eHealthMe is studying from 1,472 Betaderm users. Check the latest studies of Betaderm.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,098 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jul, 19, 2026

1,464 people reported to have side effects when taking Betaderm.
Among them, 53 people (3.62%) have Cellulitis.

Among these 53 people:

How long have people been on Betaderm when they have Cellulitis? *

What is the gender of people who have Cellulitis when taking Betaderm? *

female: 24.53 %
male: 75.47 %

What is the age of people who have Cellulitis when taking Betaderm? *

What are other drugs people take besides Betaderm? *

What are other side effects people have besides Cellulitis? *

Itching: 33 people, 62.26%
Psoriasis (immune-mediated disease that affects the skin): 33 people, 62.26%
Skin Plaque (red, scaly patches to appear on the skin): 27 people, 50.94%
Pain: 24 people, 45.28%
Emotional Distress: 20 people, 37.74%
Pain Of Skin: 20 people, 37.74%
Weight Decreased: 19 people, 35.85%
Pericarditis (inflammation of the pericardium): 18 people, 33.96%
Road Traffic Accident: 18 people, 33.96%
Sleep Apnea Syndrome: 18 people, 33.96%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 48 people, 90.57%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 18.87%
Dry Skin: 9 people, 16.98%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 3.77%
Skin Disorder (skin disease): 1 person, 1.89%
Excoriation (to tear or wear off the skin of): 1 person, 1.89%
Asthma: 1 person, 1.89%
Allergies: 1 person, 1.89%

* Approximation only. Some reports may have incomplete information.

Do you take Betaderm and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Betaderm:

Betaderm (1,472 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Betaderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,098 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,338 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone valerate (the active ingredients of Betaderm) and Betaderm (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.